10 February 2015 • By • 1 min read
The pharmaceutical sector is likely to see increased growth and profitability in coming years, argues Insync Funds Management. Earnings growth will ...
READ MOREThe oil price is likely to fall to around $30 to $50 per barrel in the short term, argues GMO investment market analyst Jeremy Grantham
READ MOREEmerging markets got off to a slow start in 2015, with Russia and Brazil the worst performers, according to HSBC. The HSBC Emerging Markets Index ...
READ MOREGlobal equity exchange-traded funds (ETFs) experienced strong trading volumes in 2014 while trading in large Australian equity ETFs declined, says ...
READ MOREThe managers of the $109 billion Future Fund have been quietly accumulating cash since September 2014, citing "uncertainty around the economic ...
READ MOREThe recent rate cut by the RBA has reinforced Credit Suisse’s view that Australian equities will provide positive returns in 2015. Credit Suisse ...
READ MOREInitial public offerings backed by private equity have outperformed non-private equity floats since 2013, according to a new report commissioned ...
READ MORETokyo-based Nikko Asset Management is still holding the Japanese equity market in high favour in 2015 as it awaits the developments of Prime Minister ...
READ MOREIt will be a "tricky year" for investors as market volatility and a tough equity market combine to create a challenging investment environment, ...
READ MOREThe Australian Council of Superannuation Investors (ACSI) has called on ASX 200 companies to increase their female board representation to 30 per cent ...
READ MORE